单位：[1]Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China[2]Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China[3]Jiading District Central Hospital Affiliated Shanghai University of Medicine and Health Sciences, Shanghai, China[4]Qilu Hospital of Shandong University, Jinan, China[5]Jiangxi People’s Hospital, Nanchang, China[6]The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China[7]Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China中山大学附属第二医院[8]The Affiliated Hospital of Southwest Medical University, Luzhou, China[9]Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China华中科技大学同济医学院附属协和医院[10]Affiliated Hospital of Guiyang Medical College, Guiyang, China[11]Zhejiang Provincial Center for Disease Control and Prevention, China[12]The First Hospital of Lanzhou University, Lanzhou, China[13]Xinhua Hospital Affiliated to Shanghai Jiao-Tong University School of Medicine, Shanghai, China[14]Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China华中科技大学同济医学院附属同济医院[15]The First Affiliated Hospital of Guangxi Medical University, Nanning, China[16]Fujian Provincial Hospital, Fujian Medical University, Fuzhou, China[17]Dalian Municipal Central Hospital, Dalian, China大连市中心医院[18]The First Hospital of Jilin University, Changchun, China[19]The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China[20]Central Hospital of Shanghai Jiading District, Shanghai, China[21]Jiangsu Province Hospital on Integration of Chinese and Western Medicine, Nanjing, China江苏省人民医院[22]The First Affiliated Hospital of Anhui Medical University, Hefei, China[23]Karamay Municipal People’s Hospital, Xinjiang, China[24]The First Affiliated Hospital of Nanjing Medical University, Nanjing, China江苏省人民医院[25]The Second Affiliated Hospital of Harbin Medical University, Harbin, China[26]Chinese People’s Liberation Army General Hospital, Beijing, China[27]Shandong Provincial Hospital affiliated to Shandong University, Jinan, China
National Natural
Science Foundation of China (grant numbers 81870560, 82088102),
the Shanghai Shenkang Hospital Development Center (grant numbers
SHDC12019101, SHDC2020CR1001A, SHDC2020CR3064B), the
Shanghai Municipal Government (grant number 20Y11905100), the
Shanghai Jiaotong University School of Medicine (grant number
DLY201801), the Ruijin Hospital (grant number 2018CR002), and the
Innovative Research Team of High-Level Local Universities in Shanghai.
第一作者单位：[1]Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China[2]Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China[3]Jiading District Central Hospital Affiliated Shanghai University of Medicine and Health Sciences, Shanghai, China
共同第一作者：
通讯作者：
通讯机构：[1]Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China[2]Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China[*1]Shanghai National Clinical Research Center for Metabolic Diseases, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, 197 Ruijin 2nd Road, Shanghai 200025, China
推荐引用方式(GB/T 7714)：
Jingya Niu,Xiaoyun Zhang,Mian Li,et al.Risk of cardiovascular disease, death, and renal progression in diabetes according to albuminuria and estimated glomerular filtration rate[J].DIABETES & METABOLISM.2023,49(2):doi:10.1016/j.diabet.2023.101420.
APA：
Jingya Niu,Xiaoyun Zhang,Mian Li,Shujing Wu,Ruizhi Zheng...&for the China Cardiometabolic Disease and Cancer Cohort 4C Study Group.(2023).Risk of cardiovascular disease, death, and renal progression in diabetes according to albuminuria and estimated glomerular filtration rate.DIABETES & METABOLISM,49,(2)
MLA：
Jingya Niu,et al."Risk of cardiovascular disease, death, and renal progression in diabetes according to albuminuria and estimated glomerular filtration rate".DIABETES & METABOLISM 49..2(2023)
